Guangdong Marubi Biotechnology Co., Ltd.

SHSE:603983 Voorraadrapport

Marktkapitalisatie: CN¥12.6b

Guangdong Marubi Biotechnology Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Huaiqing Sun

Algemeen directeur

CN¥2.1m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO12.8yrs
Eigendom CEO72.7%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur4.5yrs

Recente managementupdates

Recent updates

Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Sep 26
Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher

Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Aug 30
Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations

Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

Jun 19
Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital

Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

May 29
Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet

Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

May 07
Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?

Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

Mar 27
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion

Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

Feb 29
Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around

CEO

Huaiqing Sun (54 yo)

12.8yrs

Tenure

CN¥2,109,000

Compensatie

Mr. Huaiqing Sun is Chairman and Chief Executive Officer of Guangdong Marubi Biotechnology Co., Ltd. from January 18, 2012.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Huaiqing Sun
Chairman & CEO12.8yrsCN¥2.11m72.72%
CN¥ 9.1b
Kaihui Wang
Director & CFOno dataCN¥2.31mgeen gegevens
Lingchun Zeng
Chief Marketing Officer & Director6.5yrsCN¥2.08mgeen gegevens
Yong Cao
Independent Director1.5yrsCN¥58.30kgeen gegevens
Yi Shen
Director3.7yrsCN¥1.04mgeen gegevens
Chaowan Guo
Director3.7yrsCN¥832.00kgeen gegevens
Yalin Bi
Independent Director6.5yrsCN¥100.00kgeen gegevens
Ka Yeung Chan
Supervisor4.9yrsgeen gegevensgeen gegevens
Qingmei Chen
Chairman of the the Supervisory Board4yrsgeen gegevensgeen gegevens

4.5yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 603983 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.5 jaar).